Further, earlier studies demonstrated a worse prognosis for AML patients (adults without AMKL) whose blast cells expressed higher levels of GATA1 than patients whose blasts expressed lower levels of GATA1 [12,13]. This evidence concerns the gene GATA1 and acute myeloid leukemia.